Schedule 13D ownership disclosure
Cytokinetics Inc
Security class unavailable · CUSIP: 23282W605
Event date: 2016-08-04
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 4.9900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-16-705537
- Form type
- SC 13D
- Filer
- AMGEN INC
- CIK
- CIK 318154
- Filed
- Sep 08, 2016
- Reporting period
- Aug 04, 2016
- Description
- Schedule 13D beneficial ownership